Silymarin is a polyphenolic
flavonoid derived from milk thistle (Silybum marianum) and has anti-inflammatory, cytoprotective as well as
anticarcinogenic effects [Manna, S.K., Mukhopadlhyay, A., Van, N.T., Aggarwal, B.,
Silymarin suppresses TNF-induced activation of
NF-kappaB,
c-Jun N-terminal kinase, and apoptosis. J. Immunol. 1999; 163, 6800-6809.]. In this study, we assessed the effect of
silymarin on ultraviolet light (UV)-induced cell apoptosis in human
malignant melanoma, A375-S2 cells.
Silymarin pre-treatment reversed the effect of UV irradiation on the expression of phosphorylated Akt and phosphorylated p53 (regulated by Akt activation), followed by down-regulation of Bax and up-regulated expressions of Bcl-2 and Bcl-xL
proteins in UV-irradiated A375-S2 cells. Akt inhibitor decreased the viability of UV-irradiated cells which was treated with
silymarin. In addition, the effect of UV irradiation on the phosphorylation of
mitogen-activated protein kinase (MAPK) family members [
extracellular signal-regulated kinase (ERK), p38 and
c-Jun N-terminal kinase (JNK)] was also reversed by
silymarin. Moreover, ERK inhibitor (
PD98059) and p38 inhibitor (
SB203580) augmented UV-induced apoptosis in
silymarin treated A375-S2 cells. Consequently,
silymarin partially reduced UV-induced apoptosis by activating the Akt pathway, and
silymarin's protective effect was also exerted by MAPK family members.